Screening Isodon rubescens-Derived Vesicles Harvested at Different Periods as Carriers for the Treatment of Colitis-Associated Cancer
- 14 April 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 11 (5) , 2653-2663
Abstract
Plant-derived extracellular vesicles are of great significance in practical applications due to their availability, low immunogenicity, and effective carrier performance. Isodon rubescens-derived vesicles (IRDVs) not only have the capability for drug-carrying targeted therapy but also exhibit certain anti-inflammatory and antitumor effects as part of traditional Chinese medicine. The harvest time is closely related to the quality of its medicinal ingredients; however, whether there are differences in the IRDVs harvested at different times has yet to be explored. Herein, we analyzed the morphology and chemical composition of IRDVs collected at different time points and identified six-month-harvested IRDVs as the most suitable delivery vector. To further enhance their therapeutic potential, we modified the IRDVs with deoxycholic acid to facilitate the oral delivery of the chemotherapy drug doxorubicin (DOX). This novel nanotherapy, termed DOX-IRDVs@DA, was developed as an oral targeted treatment for colitis-associated cancer (CAC). The results demonstrated that DOX-IRDVs@DA effectively delivered DOX to colon tumor 26 (CT26) cells, induced cancer cell apoptosis by modulating apoptosis-related proteins, and inhibited the proliferation of CT26 cells. In vivo studies in a mouse model of CAC revealed that DOX-IRDVs@DA achieved superior targeted therapeutic effects, reducing the number of colonic nodules, restoring the structural integrity of the colon, and causing minimal systemic toxicity.Keywords
Funding Information
- the NMPA Key Laboratory for Quality Control of Traditional Chinese Medicine(Chinese Materia Medica and prepared slices) (KF202103)
This publication has 39 references indexed in Scilit:
- Unveiling the potential: Extracellular vesicles from plant cell suspension cultures as a promising sourceBioFactors, 2024
- A review on separation and application of plant‐derived exosome‐like nanoparticlesJournal of Separation Science, 2024
- Plant‐Derived Vesicle‐Like Nanoparticles as Promising Biotherapeutic Tools: Present and FutureAdvanced Materials, 2023
- Plant-derived nanovesicles: Further exploration of biomedical function and application potentialActa Pharmaceutica Sinica B, 2023
- Engineered Extracellular Vesicles for Cancer TherapyAdvanced Materials, 2021
- SnapShot: Extracellular VesiclesCell, 2020
- An emerging focus on lipids in extracellular vesiclesAdvanced Drug Delivery Reviews, 2020
- Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gelCarbohydrate Polymers, 2016
- Transcriptional regulation of secondary metabolite biosynthesis in plantsBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2013
- The anticancer effect of oridonin is mediated by fatty acid synthase suppression in human colorectal cancer cellsJournal of Gastroenterology, 2012